IRCT20200426047206N3招募中3 期
Evaluating the effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19: A Randomized Clinical Trial Study
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Positive PCR test
- •Age between 18-60 years
- •patient with acute respiratory infectious symptoms and lung involvement
- •non-intubated patients
排除标准
- •Allergy to Cyclosporin
- •Not willing to participate
- •Patients with cancer
- •Under treatment with immunosuppressor drugs
- •Pregnancy or breastfeeding
研究者
相似试验
已完成
不适用
Efficacy of cyclosporine therapy in the treatment of non-severe aplastic anemiaaplastic anemiaJPRN-UMIN000030453Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu34
尚未招募
4 期
To compare safety and efficacy of cyclosporine 0.05% and cyclosporine 0.09% eyedrops for dry eye (keratoconjunctivitis).Dry Eye SyndromeJPRN-UMIN000035991aser Eye Clinic Noida40
已完成
不适用
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaPER-143-08EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),
已完成
不适用
The clinical effects and safty of cyclosporine with rootine corticosteroid treatment in onset MCNSminimal change nephrotic syndromeJPRN-UMIN000004653Yokohama city university graduate school of medicine20
已完成
不适用
The efficacy of 0.05% cyclosporin eye drop for dry eye diseaseDiseases of the eye and adnexaKCT0006923Pusan National University Hospital64